Not only the mutation of key oncogenes (RAS, B-RAF, MAPK1/2) involved in skin cancer progression, but reports also suggest that chronic inflammatory pathways regulate the development of melanoma59,60. This evidence concerns the gene MAPK1 and skin cancer.